Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population

Published:2010-01-29 Issue:1 Volume:10 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Asukai Yumi,Valladares Amparo,Camps Carlos,Wood Eifiona,Taipale Kaisa,Arellano Jorge,Cassinello Alejo,Sacristán José Antonio,Dilla Tatiana

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-10-26.pdf

Reference28 articles.

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al: Cancer statistics, 2008. CA Cancer J Clin. 2008, 58: 71-96. 10.3322/CA.2007.0010.

2. Hérnandez IS, Alonso JL, Sánchez CA: [Epidemiology of lung cancer in Spain and forecast for the future]. Arch Bronconeumol. 2006, 42: 594-599.

3. Cayuela A, Rodríguez-Domínguez S, López-Campos JL, Vigil E, Otero R: [Lung cancer mortality trends in Spain between 1980 and 2005]. Arch Bronconeumol. 2008, 44: 70-74.

4. Alonso-Fernández MA, García-Clemente M, Escudero-Bueno C, Grupo ASTURPAR (Sociedad Asturiana de Patología del Aparato Respiratorio) del Cáncer del Pulmón (GACP): [Characteristics of lung cancer in a region in northern Spain]. Arch Bronconeumol. 2005, 41: 478-483.

5. Gridelli C, Ardizzoni A, Ciardiello F, Hanna N, Heymach JV, Perrone F, et al: Second-line treatment of advanced non-small cell lung cancer. J Thorac Oncol. 2008, 3: 430-440. 10.1097/JTO.0b013e318168c815.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DFT Analysis and Synthesis of Medicinally Important Pyrrolo[2,3-d]Pyrimidines by Using Thiamine Hydrochloride as a Recyclable Organocatalyst in Aqueous Media;Polycyclic Aromatic Compounds;2022-11-06

2. The Pharmacoeconomic Benefits of Pemetrexed Dose Individualization in Patients With Lung Cancer;Clinical Pharmacology & Therapeutics;2022-02-21

3. New One-Pot Pathway for the Synthesis of 2H–Pyrrolo[2,3-d]Pyrimidine-2,4-(3H)-Diones and 1H-Benzo[f]Indole-4,9-Dione Derivatives Substituted 3-Hydroxy-1,4-Naphthoquinonyl;Polycyclic Aromatic Compounds;2022-02-04

4. A Systematic Review of Economic Evaluations Assessing the Cost-Effectiveness of Licensed Drugs Used for Previously Treated Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) Negative Advanced/Metastatic Non-Small Cell Lung Cancer;Clinical Drug Investigation;2019-10-03

5. Synthesis and antiviral study of novel 4-(2-(6-amino-4-oxo-4,5-dihydro-1H-pyrrolo[2,3-d]pyrimidin-3-yl)ethyl)benzamide derivatives;Medicinal Chemistry Research;2018-10-27